Implementation of Medicare
and Medicaid Programs; - Promoting Interoperability Programs Stage
3 (CMS-10552)
Revision of a currently approved collection
No
Regular
08/31/2022
Requested
Previously Approved
36 Months From Approved
08/31/2025
4,500
3,300
29,588
21,450
0
0
The American Recovery and Reinvestment
Act of 2009 (Recovery Act) (Pub. L. 111-5) was enacted on February
17, 2009, and includes measures to modernize our nation's
infrastructure and improve affordable health care. Expanded use of
health information technology (HIT) and certified electronic health
record (EHR) technology will improve the quality and value of
America's health care. Title IV of Division B of the Recovery Act
amends Titles XVIII and XIX of the Social Security Act (the Act) by
establishing incentive payments to eligible professionals (EPs),
eligible hospitals and critical access hospitals, and Medicare
Advantage organizations participating in the Medicare and Medicaid
programs that adopt and successfully demonstrate meaningful use of
certified EHR technology (CEHRT). These Recovery Act provisions,
together with Title XIII of Division A of the Recovery Act, may be
cited as the “Health Information Technology for Economic and
Clinical Health Act” or the “HITECH Act.”. Beginning in 2018, the
names of the Medicare and Medicaid EHR Incentive Programs were
changed to the Medicare and Medicaid Promoting Interoperability
Programs. We are collecting information from participants in these
programs on objectives and measures focused on the meaningful use
of CEHRT in order to incentivize the advanced use of CEHRT to
support health information exchange, interoperability, quality
measurement, and maximizing clinical effectiveness and
efficiencies. In the FY 2023 IPPS/LTCH PPS final rule, we are
finalizing the following changes for eligible hospitals and CAHs
that attest to CMS under the Medicare Promoting Interoperability
Program that we expect to affect our collection of information
burden estimates: (1) requiring the Electronic Prescribing
Objective’s Query of Prescription Drug Monitoring Program (PDMP)
measure beginning in the CY 2023 EHR reporting period while
maintaining its associated points at 10 points with three
exclusions; (2) adopting a new Antimicrobial Use and Resistance
(AUR) Surveillance measure that would be required for eligible
hospitals and CAHs under the Medicare Promoting Interoperability
Program’s Public Health and Clinical Data Exchange Objective with
associated exclusions beginning with the CY 2024 EHR reporting
period; and (3) requiring eligible hospitals and CAHs to submit
their level of active engagement in addition to submitting
responses for the Public Health and Clinical Data Exchange
Objective required measures and the optional measures beginning
with the CY 2023 EHR reporting period. We are also modifying our
eCQM reporting and submission requirements whereby we are
increasing the total number of eCQMs to be reported from four to
six eCQMs beginning with the CY 2024 reporting period.
PL: Pub.L. 111 - 5 Title IV of Division B
Name of Law: The American Recovery and Reinvestment Act of 2009
PL: Pub.L. 111 - 5 Title XIII of Division A Name of Law: The
American Recovery and Reinvestment Act of 2009
We estimate the total annual
burden for all participants in the Medicare Promoting
Interoperability Program to be 29,588 hours at a total cost of
$1,254,510 (29,588 hours x $42.40/hour). This is an increase of
8,138 hours and $345,030 from the currently approved information
collection burden of 21,450 hours at a cost of $909,480 (adjusted
for increased wage rate).
$0
No
No
No
No
No
Yes
No
William Parham
4107864669
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Form CMS-10552 ?495.24(e) Objectives/Measures (hospitals/CAHs)
CMS-10552_Supporting_Statement_Part_A_FY 2023 Final rule 08182022_CLEAN.docx
?495.24(e) Objectives/Measures (hospitals/CAHs)